Specific inhibition of tumor cells by oncogenic EGFR specific silencing by RNA interference. - Wikidata - wikimedia - TriplyDB

Specific inhibition of tumor cells by oncogenic EGFR specific silencing by RNA interference.

Specific inhibition of tumor cells by oncogenic EGFR specific silencing by RNA interference.

http://www.wikidata.org/entity/Q37082894

about

Non-coding RNAs in lung cancer Delivery strategies and potential targets for siRNA in major cancer types NF-κB activation is an early event of changes in gene regulation for acquiring drug resistance in human adenocarcinoma PC-9 cells

P2860

Q26866521-DDB75674-2A85-40A2-8133-0DEA6DED6F29 Q38853191-F66B3BA3-B43E-44EF-94E9-A6C28D3436E0 Q55998133-FB5A1C28-0C09-4879-B322-EE179B8F4EEA

P2860

Specific inhibition of tumor cells by oncogenic EGFR specific silencing by RNA interference.

http://www.wikidata.org/entity/Q37082894

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Specific inhibition of tumor c ...... silencing by RNA interference.

@en

Specific inhibition of tumor c ...... silencing by RNA interference.

@nl

type

label

Specific inhibition of tumor c ...... silencing by RNA interference.

@en

Specific inhibition of tumor c ...... silencing by RNA interference.

@nl

prefLabel

Specific inhibition of tumor c ...... silencing by RNA interference.

@en

Specific inhibition of tumor c ...... silencing by RNA interference.

@nl

P1433

Q37082894-E97FC0EB-6ED3-4977-90AD-1A23D0B019CA

P1476

Q37082894-DB84EEA0-04CA-47B2-B5B5-74D07BD71F82

P2093

Q37082894-2F7B6034-0A47-4EDF-BA8E-C27910541C24

Q37082894-5CDD56FC-C64A-498F-9630-99720480B91E

Q37082894-6E80E214-3496-4B26-9BC9-2A926DBDBD5F

Q37082894-C4BC08F5-8943-4AD7-90CB-0AD7AB42330F

P2860

Q37082894-0AB61F71-6BA5-4F0B-BCEE-3BA7DFD8B527

Q37082894-1D47A0BC-601C-4876-AAD4-A38C05234450

Q37082894-2315A96A-063D-4888-B75C-B8F8CCEAD5A7

Q37082894-292A6CB3-3B2F-4BFC-8DA5-FCAB92492166

Q37082894-29B4A5BD-D99B-46FE-BC61-1B577E04FF65

Q37082894-357A3F33-940E-437C-A81C-FCD46059E655

Q37082894-3ACBA9A9-F52B-43A9-A06B-164986A21ECB

Q37082894-49F17247-042A-48CD-AA74-1A1C91271CFF

Q37082894-5BD3BB24-1BCE-4239-AD23-572F1F289A0E

Q37082894-6A5F2BD8-4342-46A8-B543-BD4372C09EB7

P304

Q37082894-78D5C9E7-398C-4870-9111-6A89CFE8EA2C

P31

Q37082894-6ED4D6C6-C744-48B4-9943-C94559D9950F

P356

Q37082894-29D0EAC0-C1B0-4C0A-9C74-C186C287CA9D

P407

Q37082894-B41CA65F-5E05-4F44-ABEA-1CE3F91C9179

P433

Q37082894-35512FDA-50F6-4F02-BF48-F45268A7B405

P478

Q37082894-3BAC8E75-19C4-4A4A-AA2D-D438B2F38DF6

P577

Q37082894-96BBF4BC-F64E-43A5-80F9-B8BF741E9C75

P5875

Q37082894-198DC8A6-0DB6-4B3E-899F-B7B2248D602A

P698

Q37082894-1FC0AE4F-DC67-4A64-8D51-E000F706F5AC

P932

Q37082894-2A07CB6D-F912-4837-BADC-F7EB631B3ADA

P356

JOURNAL.PONE.0073214

P1433

P1476

Specific inhibition of tumor c ...... silencing by RNA interference.

@en

P2093

Hirohiko Hohjoh

http://www.w3.org/2001/XMLSchema#string

Masaki Takahashi

http://www.w3.org/2001/XMLSchema#string

Takashi Okada

http://www.w3.org/2001/XMLSchema#string

Tomoko Chiyo

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Epidermal growth factor receptor mutations in lung cancer

Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi.

Targeted cancer therapeutics.

Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.

Oncogenic mutant forms of EGFR: lessons in signal transduction and targets for cancer therapy.

Tailor-made RNAi knockdown against triplet repeat disease-causing alleles.

Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effects.

Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers?

EGFR kinase domain mutations - functional impact and relevance for lung cancer therapy.

P304

e73214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0073214

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255959736

http://www.w3.org/2001/XMLSchema#string

P698

23951344

http://www.w3.org/2001/XMLSchema#string

P932

3738543

http://www.w3.org/2001/XMLSchema#string